Monoclonal antibodies may be a COVID-19 game changer. But will they be accessible to everyone ?

There’s been a slew of articles in leading journals relating to the results of monoclonal
antibodies in preclinical studies.
Julien Potet
MSF’s COVID-19 treatment facility in Khayelitsha, Cape Town, in South Africa. Photo by Rowan Pybus

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store